RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects
Clinical trial NCT05943379 · RECRUITING
Trial details
- NCT number
- NCT05943379
- Sponsor
- RemeGen Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-08
- Primary completion
- 2025-12-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.